Frequency and mechanism of ischemic stroke associated with malignancy: A retrospective series

European Neurology

Volumn 68, Issue 4, 2012, Pages 209-213

  Alvarez Perez F J ^a,b   Verde, I ^a   Uson Martin M ^b   Figuerola Roig, A ^b   Ballabriga Planas, J ^b   Espino Ibanez A ^b  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b HOSPITAL SON LLÀTZER   (Spain)

Author keywords

Cancer; Cerebral infarction; D dimer; Fibrinogen; Prothrombotic state; Stroke

Indexed keywords

D DIMER; FIBRINOGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; BREAST ADENOCARCINOMA; CANCER PATIENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; LUNG ADENOCARCINOMA; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; STROKE PATIENT; UTERUS CARCINOMA;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; STROKE;

EID: 84866661974     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000341343     Document Type: Article

References (26)

1. Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985; 64: 16-35.
2. Borowski A, Ghodsizad A, Gams E: Stroke as a first manifestation of ovarian cancer. J Neurooncol 2005; 71: 267-269.
3. Cornuz J, Bogousslavsky J, Schapira M, Regli F, Camenzid E: Ischemic stroke as the presenting manifestation of localized systemic cancer. Schweiz Arch Neurol Psychiatr 1988; 139: 5, Abstract
4. Lal G, Brennan TV, Hambleton J, Clark OH: Coagulopathy, marantic endocarditis, and cerebrovascular accidents as paraneoplastic features in medullary thyroid cancer. Case report and review of the literature. Thyroid 2003; 13: 601-605.
5. Grisold W, Oberndorfer S, Struhal W: Stroke and cancer: A review. Acta Neurol Scand 2009; 119: 1-16.
6. Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C: Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005; 41: 423-429.
7. Rogers LR: Cerebrovascular complications in cancer patients. Neurol Clin 2003; 21: 167-192.
8. Rogers LR: Cerebrovascular complications in patients with cancer. Semin Neurol 2010; 30: 311-319.
9. Rogers LR: Cerebrovascular complications in cancer patients. Oncology (Williston Park) 1994; 8: 23-30.
10. Hart RG, Kanter MC: Hematologic disorders and ischemic stroke; a selective review. Stroke 1990; 21: 1111-1121.
11. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM: Stroke in patients with cancer. Incidence and aetiology. Neurology 2004; 62: 2025-2030.
12. Zhang YY, Chan DKY, Cordato D, Shen Q, Sheng AZ: Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand 2006; 114: 378-383.
13. Zhang YY, Cordato D, Shen Q, et al: Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: A nested case-control study. Cerebrovasc Dis 2007; 23: 181-187.
14. Chaturvedi S, Ansell J, Recht L: Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994; 25: 1215-1218.
15. El Amrani M, Aidi S, Amarenco P: Cerebral ischemic events and anti-cancer therapy. Rev Neurol (Paris) 2003; 159: 371-380.
16. Russmann S, Winkler A, Lövblad KO, Stanga Z, Bassetti C: Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation. Eur Neurol 2002; 48: 178-180.
17. Adams HP, Bendixen BH, Kapelle LJ, and the TOAST investigators: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993; 24: 34-51.
18. Fassbender K, Dempfle CE, Mielke O, et al: Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke 1999; 30: 2101-2104.
19. Glassman AB, Jones E: Thrombosis and coagulation abnormalities associated with cancer. Ann Clin Lab Sci 1994; 24: 1-5.
20. Ageno W, Finazzi S, Steidl L, et al: Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke. Arch Intern Med 2002; 162: 2589-2593.
21. Takano K, Yamaguchi T, Kato H, Omae T: Activation of coagulation in acute cardioembolic stroke. Stroke 1991; 22: 12-16.
22. Takano K, Yamaguchi T, Uchida K: Markers of a hypercoagulable state following acute ischemic stroke. Stroke 1992; 23: 194-198.
23. Feinberg WM, Erickson LP, Bruck D, Kittelson J: Hemostatic markers in acute ischemic stroke. Association with stroke subtype, severity, and outcome. Stroke 1996; 27: 1296-1300.
24. Barber M, Langhorne P, Rumley A, Lowe GDO, Stott DJ: Hemostatic function and progressing stroke: D-dimer predicts early clinical progression. Stroke 2004; 35: 1421-1425.
25. Rudnicka AR, Mt-Isa S, Meade TW: Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: Prospective cohort study from the screening phase of the Thrombosis Prevention Trial. J Thromb Haemost 2006; 4: 2405-2410.
26. Turaj W, Słowik A, Dziedzic T, et al: Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. J Neurol Sci 2006; 246: 13-19.